The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): Potential roles in wound healing and tumor development

Cytokine and Growth Factor Reviews

Volumn 8, Issue 3, 1997, Pages 221-232

  Martins Green, M ^a   Hanafusa, H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

9E3 CEF4; Chemokine; Cytokine; Tumors; Wound healing

Indexed keywords

ANGIOGENIC FACTOR; CEF-4 CYTOKINE; CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; GENE PRODUCT; INTERLEUKIN 8; MESSENGER RNA; THROMBIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL; CANCER INHIBITION; CHEMISTRY; CHEMOTAXIS; CHICKEN; GENE EXPRESSION; GENETICS; GRANULATION TISSUE; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; PHYSIOLOGY; REVIEW; ROUS SARCOMA ONCOVIRUS; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALIA; AVES; GALLUS GALLUS; ONCOVIRINAE; ROUS SARCOMA VIRUS;

EID: 0031225156     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00016-6     Document Type: Short Survey

References (62)

1. Horuk R. Chemoattractant Ligands and Their Receptors, ed. R. Horuk. CRC Press, New York, 1996, 377.
2. Hebert CA, Luscinskas FW, Kiely JM, Luis E, Darbonne WC, Bennett GL, Liu CC, Obin MS, Gimbrone MA. Jr, Baker JB. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J. Immunol. 1990, 145, 3033-3043.
3. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Ann. Rev. Immunol. 1991, 9, 617-648.
4. Baglioni M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 1994, 55, 97-179.
5. Martins-Green M, Stoeckle M, Wimberly S, Hampe A, Hanafusa H. The 9E3/CEF4 cytokine: kinetics of secretion, processing by plasmin, and interaction with extracellular matrix. Cytokine 1996, 8, 448-459.
6. Stoeckle MY, Barker KA. Two burgeoning families of platelet factor 4-related proteins: Mediators of the inflammatory response. The New Biologist 1990, 2, 313-323.
7. Sager R, Haskill S, Anisowicz A, Trask D, Pike MC. GRO: a novel chemotactic cytokine. Adv. Expl Med. Biol. 1991, 305, 73-77.
8. Oppenheim JJ. Overview of chemokines. Adv. Expl Med. Biol. 1993, 351, 183-186.
9. Sherry B, Cerami A. Small cytokine superfamily. Curr. Opin. Immunol. 1991, 3, 56-60.
10. Mukaida N, Matsushima K. Regulation of IL-8 production and the characteristics of the receptors for IL-8. Cytokine 1992, 4, 41-53.
11. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 1994, 6, 865-873.
12. Kelner GS, Kennedy J, Bacon KB. Lymphotactin: A cytokine that represents a new class of chemokine. Science 1994, 266, 1395-1399.
13. Sugano S, Stoeckle MY, Hanafusa H. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell 1987, 49, 321-328.
14. Bedard PA, Alcorta D, Simmons DL, Luk KC, Erikson RL. Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 1987, 84, 6715-6719.
15. Anisowicz A, Bardwell L, Sager R. Constitutive over-expression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc. Natl. Acad. Sci. USA 1987, 84, 7188-7192.
16. Anisowicz A, Zajchowski D, Stenman G, Sager R. Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells. Proc. Natl. Acad. Sci. USA 1988, 85, 9645-9649.
17. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK. In vitro growth promotion in human malignant melanoma cells by fibroblast growth factor. Cancer Research 1982, 42, 3175-3180.
18. Richmond A, Lawson DH, Dixon DW, Stevens JS, Chawla RK. Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Research 1983, 43, 2106-2112.
19. Oquendo P, Alberta J, Wen D, Graycar JL, Derywek R, Stiles CD. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platlet α-granule proteins. J. Biol. Chem. 1989, 264, 4133-4137.
20. Walz A, Peveri P, Aschauer H, Bagglioni M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 1987, 149, 755-761.
21. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. Purification of human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 1987, 84, 9233-9237.
22. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Apella E, Kung HF, Leonard EJ, Oppenheim JJ. Molecular cloning of a human monocyte-derived neutophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Expl Med. 1988, 167, 1883-1893.
23. Deuel TF, Keim PS, Farmer M, Heinrikson RL. Amino acid sequence of human platelet factor 4. Proc. Natl. Acad. Sci. USA 1977, 74, 2256-2258.
24. Hermodson M, Schmer G, Kurachi K. Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. J. Biol. Chem. 1977, 252, 6276-6279.
25. Walz DA, Wu VY, de Lamo R, Dene H, McCoy LE. Primary structure of human platelet factor 4. Thromb. Res. 1977, 11, 893-898.
26. Morgan FJ, Begg FS, Chesterman CM. Primary structure of human platelet factor 4. Thromb. Haemostasis 1977, 38, 231-235.
27. Castor SW, Miller JW, Walz DA. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 1983, 80, 765-769.
28. Begg GS, Pepper DS, Chesterman CN, Morgan FJ. Complete covalent structure of human beta-thromboglobulin. Biochemistry 1978, 17, 1739-1744.
29. Stoeckle MY, Hanafusa H. Processing of 9E3 mRNA and regulation of its stability in normal and Rous sarcoma virus-transformed cells. Molec. Cell. Biol. 1989, 9, 4738-4745.
30. Martins-Green M, Tilley C, Schwarz R, Hatier C, Bissell MJ. Wound-factor-induced and cell cycle phase-dependent expression of 9E3/CEF4, the avian gro gene. Cell Regul. 1991, 2, 739-752.
31. Barker K, Hanafusa H. Expression of 9E3 mRNA is associated with mitogenicity, phosphorylation, and morphological alteration in chicken embryo fibroblasts. Molec. Cell. Biol. 1990, 10, 3813-3817.
32. Gonneville L, Martins TJ, Bédard PA. Complex expression pattern of the CEF-4 cytokine in transformed and mitogenically stimulated cells. Oncogene 1991, 6, 1825-1833.
33. Martins-Green M and Feugate JE. The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound healing cascade in vivo. Cytokine. In press.
34. Martins-Green M, Bissell MJ. Localization of 9E3/CEF-4 in avian tissues: Expression is absent in Rous sarcoma virus-induced tumors but is stimulated by injury. J. Cell Biol. 1990, 110, 581-595.
35. Martins-Green M, Aotaki-Keen A, Hjelmeland L, Bissell MJ. The 9E3 protein: immunolocalization in vivo and evidence for multiple forms in culture. J. Cell Science 1992, 101, 701-707.
36. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J. Cell Biol. 1988, 107, 2757-2767.
37. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Determination of the secondary structure of interleukin-8 by nuclear magnetic resonance spectroscopy. J. Biol. Chem. 1989, 264, 18907.
38. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three-dimensional structure of interleukin 8 in solution. Biochemistry 1990, 29, 1689-1693.
39. Baldwin ET, Weber IT, St. Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BFP, Clore GM, Gronenborn AM, Wlodawer A. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. USA 1991, 88, 502.
40. Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B. Moser B. Structure-activity of chemokines. J. Leukocyte Biol. 1995, 57, 703-711.
41. Martins-Green M, Stoeckle M, Hampe A, Wimberly S, Hanafusa H. Biochemical characterization of the 9E3/CEF4 protein and its interaction with extracellular matrix. Molec. Biol. Cell Suppl. 1993, 4, 1742a.
42. Spangler R, Joseph C, Qureshi SA, Berg KL, Foster DA. Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. Proc. Natl. Acad. Sci. USA 1989, 86, 7017-7021.
43. Qureshi SA, Joseph CK, Rim M, Maroney A, Foster DA. v-src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts. Oncogene 1991, 6, 995-999.
44. Vaingankar S. and Martins-Green M. Thrombin is a potent natural activator of the 9E3/CEF4 chemokine: Signals leading to gene activation involve the EGF receptor tyrosine kinase. (Submitted.).
45. Blobel GA, Hanafusa H. The v-src inducible gene 9E3/pCEF4 is regulated by both its promoter upstream sequence and its 3′ untranslatable region. Proc. Natl. Acad. Sci. USA 1991, 88, 1162-1166.
46. Dehbi M, Mbiguino A, Beauchemin M, Chatelain G, Bédard PA. Transcriptional activation of the CET-4/9E3 cytokine gene by pp60v-srv. Molec. Cell. Biol. 1992, 12, 1490-1499.
47. Lenardo MJ, Fan CM, Maniatis T, Baltimore D. The involvement of NF-kB in b-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 1989, 57, 287-294.
48. Dutta A, Stoeckle MY, Hanafusa H. Serum and v-src increase the level of a CCAAT-binding factor requird for transcription froma retroviral long terminal repeat. Genes and Development 1990, 4, 243-254.
49. Faber M, Sealy L. Rous sarcoma virus enhancer factor 1 is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y. J. Biol. Chem. 1990, 265, 22234-22254.
50. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 1986,83, 1670-1674.
51. Williams GT, McClanahan TK, Morimoto RI. Ela transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex. Molec. Cell. Biol. 1989.9,2574-2587.
52. Taylor IC, Kingston RE. Factor substitution in a human HSP70 gene promoter: TATA-dependent and TATA-independent interactions. Molec. Cell Biol. 1990, 10, 165-175.
53. Vaingankar SM, Martins-Green M. Pathways for activation of the avian gene 9E3/CEF4 by thrombin. Molec. Biol. Cell Suppl. 1996, 7, 52a.
54. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993, 259, 1409-1410.
55. Barker KA, Hampe A, Stoeckle MY, Hanafusa H. Transformation-associated cytokine 9E3/CEF4 is chemotactic for chicken peripheral blood mononuclear cells. J. Virol. 1993,67,3528-3533.
56. Clark R.A.F. and Henson P.M. ed. The Molecular and Cellular Biology of Wound Repair. Plenum Press. New York, 1995.
57. Martins-Green M. and Vaingankar S. Thrombin stimulation of the chemokine 9E3/CEF4 occurs via a tyrosine kinase pathway. Keystone Symposium on Wound Healing and Tissue Engineering, 1996, Abs# 404.
58. Martins-Green M, Kelly T, demons B, Hanafusa H. Angiogenic activity in vivo of the C-terminus of the 9E3/CEF4 gene product, a small inducible cytokine overexpressed during wound healing. Molec. Biol. Cell 1994, 5, 395a.
59. Gelman IH, Hanafusa H. src-specific immune regression of Rous sarcoma virus-induced tumors. Cancer Research 1993,53,915-920.
60. Bell MB, Brackenbury RW, Leslie ND, Dengen JL. Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters. J. Biol. Chem. 1990,265, 1333-1338.
61. Schmitt M, Wilhelm O, Janicke F, Magdolen V, Reuning U, Ohi H, Moniwa N, Kobayashi H, Weidle U, Graeff H. Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis. Journal of Obstetrics and Gynaecology 1995, 21, 151-165.
62. Torre EA, Fulco RA. Tumor-associated urokinase-type plasminogen activator: significance in breast cancer. European Journal of Gynaecological Oncology 1996, 17, 315-318.